EDINBURGH MOLECULAR IMAGING
DEAD

Serial Number

87136396

Owner

Edinburgh Molecular Imaging Limited

Attorney

Thomas W. Cole

Filing Date

Aug 12, 2016

Add to watchlist:

No watchlists yet
View on USPTO

EDINBURGH MOLECULAR IMAGING Trademark

Serial Number: 87136396 • Registration: 5313900

EDINBURGH MOLECULAR IMAGING is a trademark filed by Edinburgh Molecular Imaging Limited on August 12, 2016. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Edinburgh Molecular Imaging Limited

Nine Edinburgh Bio Quarter
Edinburgh EH164UX , GB

Entity Type: 16

Trademark Details

Filing Date

August 12, 2016

Registration Date

October 17, 2017

Cancellation Date

May 3, 2024

Goods & Services

Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking, supervision, life-saving and teaching apparatus and instruments, namely, medical laboratory research instruments for detecting pathogens, thermal imaging, DNA analysis; apparatus for recording, transmission or reproduction of sound or images; blank magnetic data carriers, blank optical recording discs; blank recordable CD-Rs, DVDs and USB flash drives; imaging apparatus, namely, microscopes; laser equipment for non-medical purposes, namely, laser microprobe for obtaining information on molecular structure of matter; electronic measuring apparatus and instruments, namely, microspectrophotometers; imaging instruments, namely, microscopes; scientific apparatus and instruments, namely, ultra-high vacuum chambers and parts thereof; data processing equipment; computer software for processing and displaying images on medical imaging machines; computer software for medical imaging equipment, namely, for interpreting and analysing the results of medical tests and CT scanners; computer application software for mobile phones, namely, software for processing and displaying images on medical imaging machines; computer application software for mobile phones, namely, software for interpreting and analysing the results of medical tests and CT scanners; downloadable electronic publications in the nature of reports and case studies in the field of molecular sciences and the detection, diagnosis, and treatment of diseases

Pharmaceutical preparations for the treatment of cancer; contrast media for use in medical imaging; contrast media for in vivo imaging; contrasting agents for diagnostic ultrasound imaging; contrast media for use with imaging medical equipment, namely, contrast agents and chemicals for use in modifying the spectral or luminescent properties of other materials for medical use; contrast media for use with imaging medical equipment in the nature of luminescent chemicals for use as a luminescent label; biomolecule labelling kits comprising primarily diagnostic reagents for medicinal use for use in colorimetric or luminescent labelling; gases and gas mixtures for medical imaging use; diagnostic scanning agents for medical use; diagnostic reagents for medical use in the field of cancer; reagents for the detection and diagnosis of infections and diseases; diagnostic reagent kits comprising primarily of diagnostic reagents for medical use in the field of cancer; chemical reagents for medical use

Chemical agents in the nature of contrast agents for use in molecular imaging and not for medical use; chemicals for use in molecular separation processes for use in industry and science, other than medical and veterinary use; chemical reagents for non-medical purposes for use in molecular imaging; contrast agents and chemicals for non-medical purposes for use in modifying the spectral or luminescent properties of other materials; luminescent chemicals for industrial purposes; fluorescent chemicals for industrial purposes; luminescent chemicals for industrial purposes for use as a luminescent label; fluorescent chemicals for industrial purposes for use as a fluorescent label; fluorogenic chemicals for industrial purposes; colorimetric chemicals for industrial purposes; biomolecule labelling kits consisting primarily of reagents for non-medical use in colorimetric or luminescent labelling; diagnostic reagents for scientific or research use in the field of cancer; diagnostic reagents for scientific research relating to molecular identification and digital quantification; diagnostic reagent kits comprising primarily diagnostic reagents for scientific or research use in the field of cancer

Medical services, namely, services for medical analysis; medical imaging services; human healthcare services; medical services for the diagnosis of conditions of the human body; information, consultancy and advisory services relating to all of the aforesaid services

Surgical apparatus and instruments; medical apparatus and instruments for use in molecular imaging; medical equipment and devices, namely, ultrasound, computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), single-photon emission computed tomography (SPECT) and fluorescent enabled imaging scanners and needle probe guides, and parts and fittings therefor; medical imaging apparatus; optical imaging apparatus for medical diagnostic use; medical radiation apparatus; medical imaging apparatus; diagnostic imaging apparatus for medical use; magnetic resonance imaging spectrometers for medical use; medical apparatus in the nature of apparatus for radionuclide imaging; urological imaging systems; magnetic resonance imaging (MRI) apparatus for medical diagnostic and medical purposes; probes for medical purposes, namely, fluorescent probes for imaging neutrophil elastase, fluorescent probes for imaging lung cancer, fluorescent probes for imaging dysplasia and fluorescent probes for imaging breast cancer; diagnostic imaging apparatus for medical use; magnetic resonance imaging instruments for medical purposes; medical apparatus for the detection and diagnosis of infections and diseases; medical apparatus for the detection and diagnosis of fibrosis and cancer; radioisotope apparatus for medical diagnostic use

Scientific and technological services, namely, scientific research, analysis, testing in the field of molecular sciences and the detection, diagnosis, and treatment of diseases; chemical research and analysis services; research relating to molecular sciences; analysis in the field of molecular biology; research and analysis in the field of molecular imaging and chemical reagents; scientific research for medical purposes in the area of cancerous diseases; information, consultancy and advisory services relating to all of the aforesaid services

Filing History

CANCELLED SEC. 8 (6-YR)
May 3, 2024 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Oct 17, 2022 REM1
REGISTERED-SUPPLEMENTAL REGISTER
Oct 17, 2017 R.SR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Sep 8, 2017 PREV
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Aug 31, 2017 CNTA
EXAMINER'S AMENDMENT ENTERED
Aug 31, 2017 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 31, 2017 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 31, 2017 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 31, 2017 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Aug 25, 2017 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Aug 8, 2017 PBCR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jul 21, 2017 PREV
ASSIGNED TO LIE
Jul 13, 2017 ALIE
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Jun 12, 2017 CNTA
EXAMINER'S AMENDMENT ENTERED
Jun 6, 2017 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 6, 2017 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 6, 2017 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 6, 2017 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 17, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 16, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 16, 2017 TROA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Nov 28, 2016 GPRN
PRIORITY ACTION E-MAILED
Nov 28, 2016 GPRA
PRIORITY ACTION WRITTEN
Nov 28, 2016 CPRA
ASSIGNED TO EXAMINER
Nov 25, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 17, 2016 NWOS
NEW APPLICATION ENTERED
Aug 16, 2016 NWAP